1-5 of 5
Don M. Benson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by Ex Vivo–Expanded Autologous NK Cells

Yufeng Wang, Yibo Zhang, Tiffany Hughes, Jianying Zhang, Michael A. Caligiuri, Don M. Benson, Jianhua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (16): 4006–4017.
https://doi.org/10.1158/1078-0432.CCR-17-3117
Published: 14 August 2018
View article titled, Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by <em>Ex Vivo</em>–Expanded Autologous NK Cells
Open the PDF for Fratricide of NK Cells in Daratumumab Therapy for Multiple Myeloma Overcome by <em>Ex Vivo</em>–Expanded Autologous NK Cells in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma

Don M. Benson, Jr, Adam D. Cohen, Sundar Jagannath, Nikhil C. Munshi, Gary Spitzer, Craig C. Hofmeister, Yvonne A. Efebera, Pascale Andre, Robert Zerbib, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (18): 4055–4061.
https://doi.org/10.1158/1078-0432.CCR-15-0304
Published: 14 September 2015
View article titled, A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Open the PDF for A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma in another window
Journal Articles

A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma

Douglas W. Sborov, Gerard J. Nuovo, Andrew Stiff, Thomas Mace, Gregory B. Lesinski, Don M. Benson, Jr, Yvonne A. Efebera, Ashley E. Rosko, Flavia Pichiorri, Michael R. Grever, Craig C. Hofmeister
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 5946–5955.
https://doi.org/10.1158/1078-0432.CCR-14-1404
Published: 30 November 2014
View article titled, A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma
Open the PDF for A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma

Khuda D. Khan, Christos Emmanouilides, Don M. Benson, Jr., Deborah Hurst, Pablo Garcia, Glenn Michelson, Sandra Milan, Amy K. Ferketich, Lawrence Piro, John P. Leonard, Pierluigi Porcu, Charles F. Eisenbeis, Amy L. Banks, Lei Chen, John C. Byrd, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7046–7053.
https://doi.org/10.1158/1078-0432.CCR-06-1571
Published: 04 December 2006
View article titled, A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma
Open the PDF for A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma in another window
Journal Articles

A Phase I Study of Ultra Low Dose Interleukin-2 and Stem Cell Factor in Patients with HIV Infection or HIV and Cancer

Manisha H. Shah, Aharon G. Freud, Don M. Benson, Jr., Amy K. Ferkitich, Bruce J. Dezube, Zale P. Bernstein, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3993–3996.
https://doi.org/10.1158/1078-0432.CCR-06-0268
Published: 03 July 2006
View article titled, A Phase I Study of Ultra Low Dose Interleukin-2 and Stem Cell Factor in Patients with HIV Infection or HIV and Cancer
Open the PDF for A Phase I Study of Ultra Low Dose Interleukin-2 and Stem Cell Factor in Patients with HIV Infection or HIV and Cancer in another window